Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes

Landman, Gijs W.D., Kleefstra, Nanne, van Hateren, Kornelis J.J., Groenier, Klaas H., Gans, Rijk O.B., Bilo, Henk J.G.·2010·Diabetes Care
DOI 10.2337/dc09-1380

Cited by (503)

Items 101–200 of 503

  1. Diabetes pharmacotherapy and effects on the musculoskeletal system
    Evangelia Kalaitzoglou, John L. Fowlkes, Iuliana Ristea Popescu, Kathryn M. Thrailkill · 2018 · Diabetes/Metabolism Research and Reviews
  2. Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
    Christine G. Lee, Brandy M. Heckman‐Stoddard, Dana Dabelea, Kishore M. Gadde, David A. Ehrmann, Leslie Ford, Philip C. Prorok, Edward J. Boyko, Xavier Pi-Sunyer, Amisha Wallia et al. · 2021 · Diabetes Care
  3. Diabetes and Cancer—An AACE/ACE Consensus Statement
    Yehuda Handelsman, Derek LeRoith, Zachary T. Bloomgarden, Samuel E. Dagogo-Jack, DANIEL F. EINHORN, Alan J. Garber, George Grunberger, Richard Mack Harrell, Robert F. Gagel, Harold E. Lebovitz et al. · 2013 · Endocrine Practice
  4. The Anti-Proliferative Effect of Metformin in Triple-Negative MDA-MB-231 Breast Cancer Cells Is Highly Dependent on Glucose Concentration: Implications for Cancer Therapy and Prevention
    Zordoky, Beshay N.M., Bark, Diana, Soltys, Carrie L., Sung, Miranda M., Dyck, Jason R.B. · 2014 · Biochimica et Biophysica Acta (BBA) - General Subjects
  5. Diabetes Mellitus and the Colon
    Marc S. Piper, Richard J. Saad · 2017 · Current Treatment Options in Gastroenterology
  6. Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 Diabetes
    Harold E. Lebovitz · 2011 · Diabetes Care
  7. Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial
    Sirwan M. Hadad, Philip John Coates, Lee B. Jordan, Ryan J.O. Dowling, Martin C. Chang, Susan J. Done, Colin A. Purdie, Pamela Jean Goodwin, Vuk Stambolic, Stacy L. Moulder-Thompson et al. · 2015 · Breast Cancer Research and Treatment
  8. The complexities of obesity and diabetes with the development and progression of pancreatic cancer
    Bin Bao, Zhiwei Wang, Yiwei Li, Dejuan Kong, Shadan S. Ali, Sanjeev Banerjee, Aamir Ahmad, Fazlul H. Sarkar · 2010 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  9. Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells
    Adam Naguib, Grinu Mathew, Colleen R. Reczek, Kaitlin E. Watrud, Alexandra J. Ambrico, Tali M. Herzka, Irene Casanova‐Salas, Matthew F. Lee, Nour El-Amine, Wu Zheng et al. · 2018 · Cell Reports
  10. Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy
    Choong‐kun Lee, Minkyu Jung, Inkyung Jung, Su Jin Heo, Yong Hyu Jeong, Ji Yeong An, Hyoung‐Il Kim, Jae‐Ho Cheong, Woo Jin Hyung, Sung Hoon Noh et al. · 2015 · Annals of Surgery
  11. Metformin and male reproduction: effects on S ertoli cell metabolism
    Marco Gouveia Alves, Ana Dias Martins, Cátia Vicente Vaz, Sara Correia, Paula Isabel Moreira, Pedro Fontes Oliveira, Sílvia Socorro · 2013 · British Journal of Pharmacology
  12. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort
    Dorothee M. Baur, Jens Klotsche, Ole‐Petter R. Hamnvik, Caroline Sievers, Lars Pieper, Hans‐Ulrich Wïttchen, Günter Karl Stalla, Roland Michael Schmid, Stefanos N. Kales, Christos Socrates Mantzoros · 2010 · Metabolism
  13. Diabetes and cancer II: role of diabetes medications and influence of shared risk factors
    Adedayo A. Onitilo, Jessica Marie Engel, Ingrid Glurich, Rachel V. Stankowski, Gail M. Williams, Suhail A.R. Doi · 2012 · Cancer Causes & Control
  14. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients
    Simona Bo, Giovannino Ciccone, Rosalba Rosato, Paola Villois, Giovanni Appendino, Ezio Ghigo, Giorgio Grassi · 2011 · Diabetes Obesity and Metabolism
  15. Metformin Inhibits the Growth of Human Pancreatic Cancer Xenografts
    Krisztina Kisfalvi, Aune Moro, James W. Sinnett‐Smith, Guido Eibl, Enrique Rozengurt · 2013 · Pancreas
  16. Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma
    Yaoyao Zhou, Gui‐Qi Zhu, Tian Liu, Ji-Na Zheng, Zhang Cheng, Tiantian Zou, Martin Braddock, Shen‐Wen Fu, Ming‐Hua Zheng · 2016 · Scientific Reports
  17. Pleiotropic Effects of Metformin on Cancer
    Hans-Juergen Schulten · 2018 · International Journal of Molecular Sciences
  18. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia
    Louise J. Bordeleau, Natalia Yakubovich, Gilles R. Dagenais, Julio Rosenstock, Jeffrey L. Probstfield, Pan Chang Yu, Lars Rydén, Valdis Pīrāgs, Giatgen A. Spinas, Kåre I. Birkeland et al. · 2014 · Diabetes Care
  19. The Association between Type 2 Diabetes Mellitus and Women Cancer: The Epidemiological Evidences and Putative Mechanisms
    Kyong Hye Joung, Jae‐Wook Jeong, Bon Jeong Ku · 2015 · BioMed Research International
  20. Triterpenes in cancer: significance and their influence
    Balraj Singh Gill, Sanjeev Kumar, Navgeet · 2016 · Molecular Biology Reports
  21. Metformin in prostate cancer: two for the price of one
    A. Clements, B. Gao, Shang Heng Yeap, Matthew K. Wong, Sayed Sahanawaz Ali, Howard Gurney · 2011 · Annals of Oncology
  22. Cancer-specific administrative data–based comorbidity indices provided valid alternative to Charlson and National Cancer Institute Indices
    Diana Sarfati, Jason Gurney, James Stanley, Clare E. Salmond, Peter Crampton, Elizabeth Dennett, Jonathan Koea, Neil E. Pearce · 2014 · Journal of Clinical Epidemiology
  23. Metformin: The hidden chronicles of a magic drug
    Khalid Mahmood, Muhammad Naeem, Nasir Ali Rahimnajjad · 2012 · European Journal of Internal Medicine
  24. Translating the Science of Aging into Therapeutic Interventions
    Kirkland, James L. · 2016 · Cold Spring Harbor Perspectives in Medicine
  25. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non‐muscle‐invasive bladder cancer
    Malte Rieken, Evanguelos N. Xylinas, Luis Alex Kluth, Joseph J. Crivelli, James Chrystal, Talia Faison, Yair Lotan, Pierre I. Karakiewicz, Harun Fajković, Marek Babjuk et al. · 2013 · British Journal of Urology
  26. Diabetes and Cancer
    Tahseen Ahmad Chowdhury · 2010 · QJM
  27. Insulin, Insulin Resistance, Obesity, and Cancer
    Emily J. Gallagher, Derek LeRoith · 2010 · Current Diabetes Reports
  28. Metformin and Breast Cancer: Molecular Targets
    João Faria, Gonçalo de Câmara Negalha, Ana Azevedo, Fátima Martel · 2019 · Journal of Mammary Gland Biology and Neoplasia
  29. Diabetes mellitus, hyperglycaemia and cancer
    D. Simon, Beverley Balkau · 2010 · Diabetes & Metabolism
  30. The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project
    Rebecca J. Cleveland, Kari E. North, June Stevens, Susan L. Teitelbaum, Alfred I. Neugut, Marilie D. Gammon · 2012 · Cancer Causes & Control
  31. Role of Metformin in Suppressing 1,2-Dimethylhydrazine-Induced Colon Cancer in Diabetic and Non-Diabetic Mice: Effect on Tumor Angiogenesis and Cell Proliferation
    Dalia K. Zaafar, Sawsan A. Zaitone, Yasser M. Moustafa · 2014 · PLoS ONE · Retracted
  32. Antidiabetic Drug Metformin Suppresses Endotoxin-Induced Uveitis in Rats
    Nilesh M. Kalariya, Mohammad Shoeb, Naseem H. Ansari, Srivastava Sk, Kota V. Ramana · 2012 · Investigative Ophthalmology & Visual Science
  33. Metformin, at Concentrations Corresponding to the Treatment of Diabetes, Potentiates the Cytotoxic Effects of Carboplatin in Cultures of Ovarian Cancer Cells
    Rafaela Erices, María Loreto Bravo, Pamela González, Bárbara Oliva, Dusan Racordon, Marcelo Garrido S, Carolina Ibáñez, Sumie Kato, Jorge A. Brañes, Javier Pizarro et al. · 2013 · Reproductive Sciences
  34. Endothelial cell metabolism and implications for cancer therapy
    Ulrike Harjes, Karim Bensaad, Adrian Llewellyn Harris · 2012 · British Journal of Cancer
  35. Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin
    Piotr Jan Wysocki, Bogna Wierusz‐Wysocka · 2010 · Expert Review of Molecular Diagnostics
  36. Old drug, new trick: Repurposing metformin for gynecologic cancers?
    Terri Febbraro, Ernst R. Lengyel, Iris L. Romero · 2014 · Gynecologic Oncology
  37. The Epidemiology and Molecular Mechanisms Linking Obesity, Diabetes, and Cancer
    Rosalyn Dolores Ferguson, Emily J. Gallagher, Eyal J. Scheinman, Rawan Damouni, Derek LeRoith · 2013 · Vitamins and hormones
  38. Disease-specific mortality among stage I–III colorectal cancer patients with diabetes: a large population-based analysis
    Lonneke Veronique van de Poll-Franse, Harm Reinout Haak, J.W.W. Coebergh, Maryska L.G. Janssen-Heijnen, V.E.P.P. Lemmens · 2012 · Diabetologia
  39. Metformin as an antitumor agent in cancer prevention and treatment
    Donghui Li · 2011 · Journal of Diabetes
  40. Protonation–deprotonation and structural dynamics of antidiabetic drug metformin
    Belén Hernández, Fernando Pflüger, Sergei G. Kruglik, Régis Cohen, Mahmoud Ghomi · 2015 · Journal of Pharmaceutical and Biomedical Analysis
  41. Diabetes mellitus: influences on cancer risk
    Leszek Szablewski · 2014 · Diabetes/Metabolism Research and Reviews
  42. Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma
    Donadon, Valter · 2010 · World Journal of Gastroenterology
  43. Metformin and trametinib have synergistic effects on cell viability and tumor growth inNRASmutant cancer
    Igor Vujic, Martina Sanlorenzo, Christian Posch, Rosaura Esteve‐Puig, Adam Yen, Andrew Kwong, Aaron Tsumura, Ryan M. Murphy, Klemens Rappersberger, Susana Ortiz‐Urda · 2014 · Oncotarget
  44. Overview of metformin: special focus on metformin extended release
    Shamsa Ali, Vivian Andrew Fonseca · 2012 · Expert Opinion on Pharmacotherapy
  45. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma
    Koji Harada, Tarannum Ferdous, Toyoko Harada, Yoshiya Ueyama · 2016 · International Journal of Oncology
  46. The Effects of Metformin on Ovarian Cancer
    Piyameth Dilokthornsakul, Nathorn Chaiyakunapruk, Wichai Termrungruanglert, Chayanin Pratoomsoot, Surasak Saokaew, Rosarin Sruamsiri · 2013 · International Journal of Gynecological Cancer
  47. Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead
    Rashmi R. Shah, Peter Stonier · 2018 · Journal of Clinical Pharmacy and Therapeutics
  48. Significantly increased risk of cancer in diabetes mellitus patients: A meta‐analysis of epidemiological evidence in Asians and non‐Asians
    Hiroshi Noto, Tetsuro Tsujimoto, Mitsuhiko Noda · 2011 · Journal of Diabetes Investigation
  49. Mechanism of metformin: Inhibition of DNA damage and proliferative activity in Drosophila midgut stem cell
    Hyun‐Jin Na, Joung‐Sun Park, Jung-Hoon Pyo, Shin‐Hae Lee, Ho-Jun Jeon, Young-Shin Kim, Mi‐Ae Yoo · 2013 · Mechanisms of Ageing and Development
  50. Cryptotanshinone induces G1 cell cycle arrest and autophagic cell death by activating the AMP-activated protein kinase signal pathway in HepG2 hepatoma
    In-Ja Park, Woo Kyeom Yang, Sanghee Nam, Jongki Hong, Ki Ryeol Yang, Joungmok Kim, Sung Soo Kim, Wonchae Choe, Insug Kang, Joohun Ha · 2013 · APOPTOSIS
  51. A randomized phase II study of aromatase inhibitors plus metformin in pre-treated postmenopausal patients with hormone receptor positive metastatic breast cancer
    Yannan Zhao, Chengcheng Gong, Zhonghua Wang, Jian Zhang, Leiping Wang, Sheng Zhang, Jun Cao, Zhonghua Tao, Ting Li, Biyun Wang et al. · 2017 · Oncotarget
  52. Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models
    Fuming Zi, Jing-Song He, Yi Li, Cai Wu, Li Yang, Yang Yang, Lijuan Wang, Dong-Hua He, Yi Zhao, Wen-Jun Wu et al. · 2014 · Cancer Letters
  53. Metformin reduces the risk of cancer in patients with type 2 diabetes
    Hae Jin Kim, Soojin Lee, Ki Hong Chun, Ja Young Jeon, Seung Jin Han, Dae Jung Kim, Young Seol Kim, Jeong‐Taek Woo, Moonsuk Nam, Sei Hyun Baik et al. · 2018 · Medicine
  54. Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort
    Rajesh Krishnamoorthi, Bijan J. Borah, Herbert C. Heien, Ananya Das, Amitabh Chak, Prasad G. Iyer · 2016 · Gastrointestinal Endoscopy
  55. Metformin promotes the proliferation and differentiation of murine preosteoblast by regulating the expression of sirt6 and oct4
    Wei Mu, Zhuoran Wang, Chuanyu Ma, Yunyun Jiang, Nannan Zhang, Kaiqiang Hu, Liyuan Li, Zhao Wang · 2017 · Pharmacological Research
  56. Metformin lowers the threshold for stress-induced senescence: A role for the microRNA-200 family and miR-205
    Sílvia Cufí, Alejandro Vázquez‐Martín, Cristina Oliveras‐Ferraros, Rosa Quirantes‐Piné, Antonio Segura‐Carretero, Vicente Micol, Jorge Joven, Joaquim Bosch‐Barrera, Sonia Del Barco, Begoña Martı́n-Castillo et al. · 2012 · Cell Cycle
  57. Metformin and Cancer
    Natalia G. Vallianou, Angelos A Evangelopoulos, Christos E. Kazazis · 2013 · The Review of Diabetic Studies
  58. Diabetes, metformin use, and colorectal cancer survival in postmenopausal women
    Furha Iram Cossor, Lucile Lauren Adams-Campbell, Rowan T. Chlebowski, Marc James Gunter, Karen Johnson, Robert E. Martell, Anne McTiernan, Michael Steven Simon, Thomas E. Rohan, Robert B. Wallace et al. · 2013 · Cancer Epidemiology
  59. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase
    Qianqian Guo, Zhiyan Liu, Lili Jiang, Mengjie Liu, Jiequn Ma, Chengcheng Yang, Lili Han, Kejun Nan, Xuan Liang · 2016 · Molecular Medicine Reports
  60. Mechanisms of metformin inhibiting cancer invasion and migration.
    Yong Chang Chen, He Li, Jing Wang · 2020 · PubMed Central
  61. Metformin effects revisited
    Paula Andújar-Plata, Xavier Pi-Sunyer, Blandine Laferrère · 2011 · Diabetes Research and Clinical Practice
  62. Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms
    Yong Zhang, Weijia Kong, Jian‐Dong Jiang · 2017 · Science China Life Sciences
  63. Survival Benefit of Metformin Adjuvant Treatment For Pancreatic Cancer Patients: a Systematic Review and Meta-Analysis
    Wan, Guoxing, Sun, Xue, Li, Fang, Wang, Xuanbin, Li, Chen, Li, Hongliang, Yu, Xianjun, Cao, Fengjun · 2018 · Cellular Physiology and Biochemistry
  64. Metformin Mitigates DPP-4 Inhibitor-Induced Breast Cancer Metastasis via Suppression of mTOR Signaling
    Emi Kawakita, Fan Yang, Asako Kumagai, Yuta Takagaki, Munehiro Kitada, Yasuo Yoshitomi, Takayuki Ikeda, Yuka Nakamura, Yasuhito Ishigaki, Keizo Kanasaki et al. · 2020 · Molecular Cancer Research
  65. Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study
    Chien‐Ming Lin, Huiling Huang, Fang-Ying Chu, Hueng‐Chuen Fan, Hung-An Chen, Der‐Ming Chu, Li‐Wei Wu, Chung‐Ching Wang, Wei‐Liang Chen, Shih‐Hua Lin et al. · 2015 · PLoS ONE
  66. Metformin Increases Overall Survival in Patients with Diabetes Undergoing Surgery for Colorectal Cancer
    Tina Fransgaard, Lau Caspar Thygesen, Ismail Gögenür · 2015 · Annals of Surgical Oncology
  67. Diabetes-Related Dysfunction of the Small Intestine and the Colon: Focus on Motility
    Viktor József Horváth, Zsuzsanna Putz, Ferenc Izbéki, Anna Erzsébet Körei, László Gerő, Csaba Lengyel, Péter Kempler, Tamás T. Várkonyi · 2015 · Current Diabetes Reports
  68. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma
    Malte Rieken, Evanguelos N. Xylinas, Luis Alex Kluth, Joseph J. Crivelli, James Chrystal, Talia Faison, Yair Lotan, Pierre I. Karakiewicz, Maxine Sun, Harun Fajković et al. · 2013 · Urologic Oncology Seminars and Original Investigations
  69. LKB1 promotes metabolic flexibility in response to energy stress
    Seth J. Parker, Robert U. Svensson, Ajit S. Divakaruni, Austin E.Y.T. Lefebvre, Anne N. Murphy, Reuben J. Shaw, Christian M. Metallo · 2016 · Metabolic Engineering
  70. New insights into antidiabetic drugs: Possible applications in cancer treatment
    Vahid Shafiei‐Irannejad, Nasser Samadi, Roya Salehi, Bahman Yousefi, Nosratollah Zarghami · 2017 · Chemical Biology & Drug Design
  71. Dose-Dependent Relationship Between Metformin and Colorectal Cancer Occurrence Among Patients with Type 2 Diabetes—A Nationwide Cohort Study
    Yu‐Tang Chang, Hsiang‐Lin Tsai, Ya-Ting Kung, Yung‐Sung Yeh, Ching‐Wen� Huang, Cheng‐Jen Ma, Herng‐Chia Chiu, Jaw‐Yuan Wang · 2018 · Translational Oncology
  72. Dissecting the Mechanisms Underlying Unusually Successful Human Health Span and Life Span
    Sofiya Milman, Nir Barzilai · 2015 · Cold Spring Harbor Perspectives in Medicine
  73. Metformina – mechanizmy działania i zastosowanie w terapii cukrzycy typu 2[i][/i]
    Marzena Grzybowska, Joanna Bober, Maria Olszewska · 2011 · Postępy Higieny i Medycyny Doświadczalnej
  74. Activation of AMP-Activated Protein Kinase Inhibits the Proliferation of Human Endothelial Cells
    Kelly J. Peyton, Xiaoming Liu, Yajie Yu, Benjamin Yates, William Durante · 2012 · Journal of Pharmacology and Experimental Therapeutics
  75. The Effect of Metformin on Mortality Following Cancer among Patients with Diabetes
    Iliana Carolina Lega, Prakesh S. Shah, David Margel, Joseph Beyene, Paula A. Rochon, Lorraine Lucille Lipscombe · 2014 · Cancer Epidemiology Biomarkers & Prevention
  76. Molecular Pathways: Preclinical Models and Clinical Trials with Metformin in Breast Cancer
    Alastair Mark Thompson · 2014 · Clinical Cancer Research
  77. Therapeutic Potential of an Anti-diabetic Drug, Metformin: Alteration of miRNA expression in Prostate Cancer Cells
    Çığır Biray Avcı, Ece Harman, Yavuz Dodurga, Sunde Yılmaz Süslüer, Cumhur Gündüz · 2013 · Asian Pacific Journal of Cancer Prevention
  78. Diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: Results from the women's health initiative
    Zhihong Gong, Aaron K. Aragaki, Rowan T. Chlebowski, JoAnn Elisabeth Manson, Thomas E. Rohan, Chu Chen, Mara Z. Vitolins, Lesley Fels Tinker, Erin S. LeBlanc, Lewis H. Kuller et al. · 2015 · International Journal of Cancer
  79. Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy
    Obiageli Ezewuiro, Tatyana A. Grushko, Masha Kocherginsky, Mohammed Habis, Jean A. Hurteau, Kathryn A. Mills, JESSICA HUNN, Olufunmilayo Ibironke Olopade, Gini F. Fleming, Iris L. Romero · 2016 · PLoS ONE
  80. Biguanides drugs: Past success stories and promising future for drug discovery
    Oleksandr Grytsai, Iuliia Myrgorodska, Stéphane Rocchi, Cyril Ronco, Rachid Benhida · 2021 · European Journal of Medicinal Chemistry
  81. Clinical Characteristics and Prognostic Factors of Adenoid Cystic Carcinoma of the Head and Neck
    Yunsuk Choi, Sung‐Bae Kim, Dok Hyun Yoon, Ji Youn Kim, Sang‐wook Lee, Kyung‐Ja Cho · 2013 · The Laryngoscope
  82. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus
    H. Qiu, G G Rhoads, J. A. Berlin, Stephen W. Marcella, Kitaw Demissie · 2012 · Diabetes Obesity and Metabolism
  83. Metformin Does Not Reduce Markers of Cell Proliferation in Esophageal Tissues of Patients With Barrett’s Esophagus
    Amitabh Chak, Navtej S. Buttar, Nathan R. Foster, Drew K. Seisler, Norman E. Marcon, Robert E. Schoen, Marcia Roxana Cruz-Correa, Gary W. Falk, Prateek Sharma, Chin Hur et al. · 2014 · Clinical Gastroenterology and Hepatology
  84. Metformin Association with Lower Prostate Cancer Recurrence in Type 2 Diabetes: a Systematic Review and Meta-analysis
    In Cheol Hwang, Sang Min Park, Doosup Shin, Hong Yup Ahn, Malte Rieken, Shahrokh François Shariat · 2015 · Asian Pacific Journal of Cancer Prevention
  85. Increased Risk of Gastrointestinal Malignancy in Patients with Diabetes Mellitus and Correlations with Anti-Diabetes Drugs: A Nationwide Population-based Study in Taiwan
    Chun-Chih Chiu, Chin‐Chou Huang, Yu‐Chun Chen, Tzeng‐Ji Chen, Ying Jie Liang, Shing‐Jong Lin, Jaw‐Wen Chen, Hsin‐Bang Leu, Wan‐Leong Chan · 2013 · Internal Medicine
  86. Water soluble Ru( ii )–arene complexes of the antidiabetic drug metformin: DNA and protein binding, molecular docking, cytotoxicity and apoptosis-inducing activity
    Durairaj Gopalakrishnan, Mani Ganeshpandian, Loganathan Rangasamy, Nattamai S. P. Bhuvanesh, X. Janet Sabina, J. Karthikeyan · 2017 · RSC Advances
  87. Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT
    Simon J. Griffin, Mary Angelyn Bethel, Rury R. Holman, Kamlesh K. Khunti, Nicholas J. Wareham, Gwen Brierley, Melanie Jane Davies, Andrew Dymond, Rose Eichenberger, Philip Hugh Evans et al. · 2018 · Health Technology Assessment
  88. Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo
    Shintaro Fujihara, Kiyohito Kato, Asahiro Morishita, Hisakazu Iwama, Tomoko Nishioka, Taiga Chiyo, Noriko Nishiyama, Hisaaki Miyoshi, Mitsuyoshi Kobayashi, Hideki Kobara et al. · 2015 · International Journal of Oncology
  89. Use of Metformin and Survival of Diabetic Women with Breast Cancer
    Paul J.H.L. Peeters, Marloes T. Bazelier, Peter Vestergaard, Hubert G. M. Leufkens, Marjanka K. Schmidt, Frank de Vries, Marie L. De Bruin · 2013 · Current Drug Safety
  90. AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway
    Carlotta Petti, Claudia Vegetti, Alessandra Molla, Ilaria Bersani, Loredana Cleris, Kirsty J. Mustard, Franca Formelli, David Grahame Hardie, Marialuisa Sensi, Andrea Anichini · 2012 · Melanoma Research
  91. Metformin for non-small cell lung cancer patients: Opportunities and pitfalls
    Antonin Lévy, J. Doyen · 2018 · Critical Reviews in Oncology/Hematology
  92. Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis
    Taylor Teague, Stephanie R. Payne, Bryan T. Kelly, Timothy M. Dempsey, Rozalina G. McCoy, Lindsey R. Sangaralingham, ANDREW HAR LIMPER · 2022 · Respiratory Research
  93. Diabetes and cancer: Epidemiology and potential mechanisms
    Hans‐Georg Joost · 2014 · Diabetes and Vascular Disease Research
  94. Incretin Therapies in the Management of Elderly Patients with Type 2 Diabetes Mellitus
    Isabelle Bourdel‐Marchasson, Anja Schweizer, Sylvie Dejager · 2011 · Hospital Practice
  95. Metformin inhibits age-related centrosome amplification in Drosophila midgut stem cells through AKT/TOR pathway
    Hyun-Jin Na, Joung‐Sun Park, Jung-Hoon Pyo, Ho-Jun Jeon, Young-Shin Kim, Robert Arking, Mi‐Ae Yoo · 2015 · Mechanisms of Ageing and Development
  96. Diabetes Medication Use in Association with Survival among Patients of Breast, Colorectal, Lung, or Gastric Cancer
    Michelle L. Baglia, Yong Cui, Tao Zheng, Gong Yang, Honglan Li, Mingrong You, Liling Xu, Harvey J. Murff, Yu‐Tang Gao, Wei Zheng et al. · 2018 · Cancer Research and Treatment
  97. Insulin Breast Cancer Connection: Confirmatory Data Set the Stage for Better Care
    Andrea DeCensi, Alessandra Gennari · 2010 · Journal of Clinical Oncology
  98. TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer
    Marc Pujalte‐Martin, Delphine Borchiellini, Brice Thamphya, Aline Guillot, Jean-Baptiste Paoli, Dominique Besson, Werner Hilgers, Frank Priou, Claude El Kouri, Benjamin Hoch et al. · 2021 · Clinical Genitourinary Cancer
  99. Antiangiogenic effects of N6‐isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation
    Simona Pisanti, Paola Picardi, Elena Ciaglia, Luigi Margarucci, Roberto Ronca, Arianna Giacomini, Anna Maria Malfitano, Agostino Casapullo, Chiara Laezza, Patrizia Gazzerro et al. · 2013 · The FASEB Journal
  100. Anticancer Effects of Metformin and Its Potential Use as a Therapeutic Agent for Breast Cancer
    Amy Guppy, Mariam Jamal‐Hanjani, Lisa M. Pickering · 2011 · Future Oncology